packageAxitinib

axitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Axitinib is a protein kinase inhibitor used to treat kidney cancer, especially renal cell carcinoma. It is an approved medicine and is authorised in the European Union for renal cell carcinoma.

Summary written by glm-5.3-flash from Wikidata Q4830631 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:axitinib
ATC codes:L01EK01
DrugBank:DB06626
PubChem CID:6450551
ChEBI:66910
Wikidata:Q4830631
formula:C22H18N4OS
molar mass:386.473 g/mol (PubChem CID 6450551)
logP:4.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown